Nitazoxanide is a broad-spectrum antiparasitic and antiprotozoal agent commonly used to treat infections such as giardiasis and cryptosporidiosis by inhibiting key metabolic pathways in susceptible organisms. With a well-established safety profile, it is a reliable option for gastrointestinal infections and other parasitic conditions. Emerging research continues to explore its potential beyond antiparasitic use.
This is a compounded preparation. Compounded preparations are not reviewed or approved by the U.S. Food and Drug Administration (FDA) for safety, efficacy, or quality.
